Peroxisome proliferator-activated receptors in the cardiovascular system.
about
PPAR-alpha agonists as novel antiepileptic drugs: preclinical findingsFeeding a protein-restricted diet during pregnancy induces altered epigenetic regulation of peroxisomal proliferator-activated receptor-α in the heart of the offspringOxidative stress causes ERK phosphorylation and cell death in cultured retinal pigment epithelium: prevention of cell death by AG126 and 15-deoxy-delta 12, 14-PGJ2Peroxisome proliferator-activated receptor agonists prevent 25-OH-cholesterol induced c-jun activation and cell deathRelationship between PPARalpha activation and NO on proximal tubular Na+ transport in the ratActivation of the peroxisome proliferator-activated receptor alpha protects against myocardial ischaemic injury and improves endothelial vasodilatation.Is the cardiovascular system a therapeutic target for cannabidiol?Time-dependent vascular effects of Endocannabinoids mediated by peroxisome proliferator-activated receptor gamma (PPARγ)Bisphenol A diglycidyl ether (BADGE) is a PPARgamma agonist in an ECV304 cell lineTranscriptome alteration in the diabetic heart by rosiglitazone: implications for cardiovascular mortality.Fatty acid-binding protein 5 (FABP5) regulates cognitive function both by decreasing anandamide levels and by activating the nuclear receptor peroxisome proliferator-activated receptor β/δ (PPARβ/δ) in the brainRadix Stellariae extract prevents high-fat-diet-induced obesity in C57BL/6 mice by accelerating energy metabolismCannabinoids go nuclear: evidence for activation of peroxisome proliferator-activated receptors.Collecting duct-specific deletion of peroxisome proliferator-activated receptor gamma blocks thiazolidinedione-induced fluid retentionEndogenous epoxygenases are modulators of monocyte/macrophage activityThe Role of PPARα Activation in Liver and Muscle.Activation of PPARs α, β/δ, and γ Impairs TGF-β1-Induced Collagens' Production and Modulates the TIMP-1/MMPs Balance in Three-Dimensional Cultured Chondrocytes.Peroxisome proliferator-activated receptors in atherosclerosis and inflammation--an update.Peroxisome proliferator-activated receptor (PPAR) modulators: diabetes and beyond.Alanine for proline substitution in the peroxisome proliferator-activated receptor gamma-2 (PPARG2) gene and the risk of incident myocardial infarction.High-density lipoprotein hydrolysis by endothelial lipase activates PPARalpha: a candidate mechanism for high-density lipoprotein-mediated repression of leukocyte adhesion.Rosiglitazone causes cardiotoxicity via peroxisome proliferator-activated receptor γ-independent mitochondrial oxidative stress in mouse hearts20-Hydroxyeicosatetraenoic acid inhibits ATP-induced COX-2 expression via peroxisome proliferator activator receptor-α in vascular smooth muscle cells.Activation of PPAR gamma receptors reduces levodopa-induced dyskinesias in 6-OHDA-lesioned rats.PPAR-alpha effects on the heart and other vascular tissues.Inhibition of leukocyte-endothelial interactions by oxidized omega-3 fatty acids: a novel mechanism for the anti-inflammatory effects of omega-3 fatty acids in fish oil.Rosiglitazone Restores Endothelial Dysfunction in a Rat Model of Metabolic Syndrome through PPARγ- and PPARδ-Dependent Phosphorylation of Akt and eNOS.The role of PPAR activation during the systemic response to brain injury.Inhibition of smooth muscle proliferation by urea-based alkanoic acids via peroxisome proliferator-activated receptor alpha-dependent repression of cyclin D1.Peroxisome proliferator-activated receptors and cardiovascular remodeling.The role of peroxisome proliferator-activated receptors in pulmonary vascular disease.The cardioprotective power of leavesGemfibrozil, a lipid lowering drug, inhibits the activation of primary human microglia via peroxisome proliferator-activated receptor β.Peroxisome Proliferator-Activated Receptors and the Heart: Lessons from the Past and Future Directions.Regio- and stereospecific syntheses and nitric oxide donor properties of (E)-9- and (E)-10-nitrooctadec-9-enoic acidsPPAR-gamma in the Cardiovascular SystemAnticancer Properties of PPARalpha-Effects on Cellular Metabolism and Inflammation.Nutrigenomics: concepts and applications to pharmacogenomics and clinical medicine.Loss of PPARα perpetuates sex differences in stroke reflected by peripheral immune mechanisms.Sex differences and the role of PPAR alpha in experimental stroke.
P2860
Q21090748-8686782F-964E-42F0-8AD6-201929837169Q24635109-1376E596-8772-48E2-8518-A023242CA965Q24792721-44D5332B-E3FC-4830-AA2C-1D9F32AB1E8AQ24795891-840B1F3E-83B2-48E4-B6CD-AF134353D43FQ24799696-CC9AA35A-BF82-44CE-98A3-3ECD5D5E8FDCQ24806958-3401812A-E1AE-4B2F-BA9E-875131536BF7Q26865370-252DCC43-2BC9-4701-9AD7-EECA4367551FQ28243980-DA2FBF3E-A3E8-43C6-A026-B61AB0C0940FQ28344848-D94772DB-F541-4C1F-A28C-9F7FA0E91B39Q33354126-E392AEE5-93FB-4505-8403-1D3091F16C1DQ33556230-1648D033-0272-4ABE-8D5C-808EFB324195Q33677996-F30AC219-1DE7-4C45-9D7C-3197830F9632Q33845285-0C8B8F0E-A1CA-4D0D-ACFB-52354913979FQ33878917-75CE2B66-CE2A-44AE-A56D-2235D77D4DD5Q34058704-F6E8603C-F196-4EB6-9E42-A02607295000Q34106233-4BAF2104-B739-490A-BA2B-BDD47BF6E4A1Q34210856-9A4FFEB7-35E0-45E0-88CF-690D588CB51EQ34290988-79B2465A-8D3D-4790-83E8-85E82E779E3FQ34405645-E0360FCD-0CEA-443E-B6D0-7DFF9ADEEB32Q34509923-00DF1E26-CA7A-472A-986A-E99EFEC6E553Q34510249-9F1DA4D1-D848-4F8D-B064-9C0419196965Q34569388-B7EA3E7B-8270-43C1-8BC0-65BE82D519F4Q35036189-88D33103-D8F7-4BBD-B486-CCFBC7992C6EQ35070472-D15329F7-ADE7-4C05-A9D4-EBAF90E5117CQ35080447-0497E5FA-BE0C-4EA2-8186-26632D9DC7E4Q35081219-DDCAA82F-6AEC-4820-BBCB-35B4861A45CFQ35608658-0093D0B1-CB65-4D2A-9066-FF56530E2CF3Q35637313-006D42F7-BB07-4D7E-BCEF-362A38F42E8BQ35865401-74D03CDC-BBC3-48EE-9B2C-FBC31A1E80BEQ35890826-0CB655B2-7936-485E-A338-F60A90412F57Q35925357-C22D2DE0-BE0D-4803-A5F7-2C3C3B31D08DQ35992138-6318FD02-F1C2-4AC2-AF60-BB7A44197C45Q36074920-1022E3CF-A773-4138-B505-E450E21D2986Q36261125-6A3DFDAA-0FBA-437C-B828-861A245966C6Q36347304-E9F73666-4A30-4AE2-AA4D-A8338192265CQ36426786-5DC00FFF-FDC8-4307-A56B-0C35B99C6210Q36675898-071FD4BA-77FA-4D30-B2E1-28CA8C3DFF23Q36772839-63370158-89D1-40D2-9A75-54529955F494Q36892763-FF2A671D-3522-401E-B93E-0DB33C0E5CB2Q36892933-944DACEE-48F5-43C2-BADE-451CE0347360
P2860
Peroxisome proliferator-activated receptors in the cardiovascular system.
description
2000 nî lūn-bûn
@nan
2000 թուականի Մարտին հրատարակուած գիտական յօդուած
@hyw
2000 թվականի մարտին հրատարակված գիտական հոդված
@hy
2000年の論文
@ja
2000年論文
@yue
2000年論文
@zh-hant
2000年論文
@zh-hk
2000年論文
@zh-mo
2000年論文
@zh-tw
2000年论文
@wuu
name
Peroxisome proliferator-activated receptors in the cardiovascular system.
@ast
Peroxisome proliferator-activated receptors in the cardiovascular system.
@en
type
label
Peroxisome proliferator-activated receptors in the cardiovascular system.
@ast
Peroxisome proliferator-activated receptors in the cardiovascular system.
@en
prefLabel
Peroxisome proliferator-activated receptors in the cardiovascular system.
@ast
Peroxisome proliferator-activated receptors in the cardiovascular system.
@en
P2860
P356
P1476
Peroxisome proliferator-activated receptors in the cardiovascular system.
@en
P2093
D Bishop-Bailey
P2860
P304
P356
10.1038/SJ.BJP.0703149
P407
P577
2000-03-01T00:00:00Z